ClassID:

20192

A61K31/025 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Halogenated hydrocarbons carbocyclic

Sub-classes:
Recent Application in this class:
#1
20260000638
2026-01-01

METHODS OF INDUCING ANESTHESIA

#2
20240383827
2024-11-21

DIFLUOROCARBENE RADIOSYNTHESIS

#3
20240294567
2024-09-05

FLUORINATED AND ALKYLATED BILE ACIDS

#4
20230390211
2023-12-07

COMPOSITION FOR INCREASING EXPRESSION OF BLOOD COAGULATION FACTOR GENE, COMPRISING CORE-SHELL STRUCTURED MICROPARTICLES AS ACTIVE INGREDIENT

#5
20230255930
2023-08-17

METHOD OF INCREASING THE POPULATION OF COPROCOCCUS SPP. IN THE GUT MICROBIOME

#6
20230066008
2023-03-02

ANTIPARASITIC COMPOSITION

#7
20220288011
2022-09-15

METHODS OF INDUCING ANESTHESIA

#8
20220233489
2022-07-28

KITS FOR DERMAL CARE

#9
20220002339
2022-01-06

Fluorinated and alkylated bile acids

#10
20210322363
2021-10-21

METHODS OF INDUCING ANESTHESIA

#11
20210322337
2021-10-21

TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS

#12
20210113668
2021-04-22

Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient

#13
20200163903
2020-05-28

Buffered Oxygen Therapeutic

#14
20190343801
2019-11-14

COMPOSITIONS AND METHODS FOR CONTROLLING NATURAL KILLER CELL ACTIVATION AND FUNCTION

#15
20190083220
2019-03-21

Oral compositions and methods of use

#16
20190000793
2019-01-03

METHODS OF INDUCING ANESTHESIA

#17
20180303767
2018-10-25

TREATMENT OF OXIDATIVE STRESS DISORDERS INCLUDING CONTRAST NEPHROPATHY, RADIATION DAMAGE AND DISRUPTIONS IN THE FUNCTION OF RED CELLS

#18
20180164408
2018-06-14

LIDAR based 3-D imaging with far-field illumination overlap

#19
20180116997
2018-05-03

Methods of inducing anesthesia

#20
20180021266
2018-01-25

Buffered oxygen therapeutics

#21
20170189349
2017-07-06

Onychomycosis treatment system and method

#22
20170027840
2017-02-02

Optical treatment methods

#23
20160296496
2016-10-13

Methods of inducing anesthesia

#24
20160228380
2016-08-11

IMPREGNANATION OF OXYGEN CARRIER COMPOUNDS INTO CARRIER MATERIALS PROVIDING COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS AND BURNS

#25
20160022601
2016-01-28

Optical treatment methods

#26
20150232398
2015-08-20

AZULENE AND DERIVATIVES THEREOF AS COLORANTS

#27
20150157596
2015-06-11

Methods of inducing sedation

#28
20150126476
2015-05-07

Topical compositions for use in the prevention and/or treatment of dermatitis

#29
20150119457
2015-04-30

ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY

#30
20150050219
2015-02-19

COLOURED SOLUTION IN PARTICULAR FOR USE IN SURGICAL METHODS FOR THE TREATMENT OF THE BODIES OF HUMANS OR ANIMALS

#31
20140371329
2014-12-18

Buffered oxygen therapeutic

#32
20140018414
2014-01-16

METHODS OF INDUCING ANESTHESIA

#33
20130316021
2013-11-28

TREATMENT OF RESPIRATORY DISEASES

#34
20130165839
2013-06-27

Optical treatment methods

#35
20130096204
2013-04-18

Buffered oxygen therapeutic

#36
20130096190
2013-04-18

PERFLUOROCARBON GEL FORMULATIONS

#37
20130059021
2013-03-07

PERFLUORO(N-BUTYLCYCLOHEXANE) COMPOSITIONS AND USES THEREOF

#38
20130053757
2013-02-28

Tattoo removal system and method

#39
20130022692
2013-01-24

Expression Modulator For Clock Gene Period

#40
20120083510
2012-04-05

Perfluorocarbons for use in treating pruritus

#41
20110269776
2011-11-03

Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells

#42
20110257141
2011-10-20

Transdermal testosterone formulation for minimizing skin residues

#43
20110229575
2011-09-22

DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS

#44
20110086923
2011-04-14

Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons

#45
20100267842
2010-10-21

Emulsions of Perfluorocarbons

#46
20100144861
2010-06-10

Perfluorocarbon gel formulations

#47
20100144597
2010-06-10

Novel combinatorial approaches to enhancing oxygen transport to tissues

#48
20090280055
2009-11-12

Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods

#49
20090105276
2009-04-23

Lindane lotion and methods

#50
20090069364
2009-03-12

PHARMACEUTICAL COMPOSITIONS OF 5-ALPHA-REDUCTASE INHIBITORS AND METHODS OF USE THEREOF

#51
20080318982
2008-12-25

Pharmaceutical Combination for the Treatment of Luts

#52
20080075710
2008-03-27

Herbal composition for treating hangovers

#53
20070225379
2007-09-27

TRANSDERMAL DELIVERY OF SYSTEMICALLY ACTIVE CENTRAL NERVOUS SYSTEM DRUGS

#54
20070190183
2007-08-16

Treatment of respiratory diseases

#55
20070142480
2007-06-21

Alleviation of pain in osteoarthritis by means of intra-articular implantation of perfluorodecalin.

#56
20070054859
2007-03-08

Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation

#57
20070026024
2007-02-01

Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant

#58
20060263302
2006-11-23

Systemic oxygenation via gastric perfusion with perfluorocarbon (PFC)

#59
20060153905
2006-07-13

Transdermal pharmaceutical formulation for minimizing skin residues